Ferric derisomaltose
- Generic Name
- Ferric derisomaltose
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H34FeO16
- CAS Number
- 1345510-43-1
- Unique Ingredient Identifier
- AHU547PI9H
- Background
Iron deficiency is an extremely common condition and is the most frequent cause of anemia worldwide. Iron deficiency results when iron intake, iron stores, and loss of iron from the body do not adequately support production of erythrocytes, also known as red blood cells. Though it is generally considered non life-threatening, iron deficiency may considerably...
- Indication
This drug is indicated for the treatment of iron deficiency anemia in adult patients who have experienced intolerance to oral iron preparations or insufficient clinical response to orally administered iron. Ferric derisomaltase is also indicated for patients with non-hemodialysis dependent chronic kidney disease. In Australia and United Kingdom, ferric deris...
- Associated Conditions
- Iron Deficiency Anemia (IDA), Requirement for rapid iron delivery
- Associated Therapies
- -
IRONHEART: Intravenous Iron in Non-ischaemic Heart Failure
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-08-07
- Target Recruit Count
- 16
- Registration Number
- NCT06542822
- Locations
- 🇬🇧
University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life
- Conditions
- Interventions
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- China-Japan Friendship Hospital
- Target Recruit Count
- 170
- Registration Number
- NCT05991128
- Locations
- 🇨🇳
China-Japan Friendship Hospital, Beijing, Chaoyang District, China
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
- Conditions
- Interventions
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2023-08-15
- Lead Sponsor
- China-Japan Friendship Hospital
- Target Recruit Count
- 146
- Registration Number
- NCT05971732
- Locations
- 🇨🇳
China-Japan Friendship Hospital, Beijing, Beijing, China
Iron Deficiency Anemia (IDA) and the Brain
- Conditions
- Interventions
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 120
- Registration Number
- NCT05929729
- Locations
- 🇺🇸
City of Hope Blood Donor Center, Duarte, California, United States
🇺🇸Cedar Sinai Blood Bank, Los Angeles, California, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
Monoferric for Prenatal Iron Deficiency
- Conditions
- Interventions
- First Posted Date
- 2023-03-10
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 80
- Registration Number
- NCT05763043
- Locations
- 🇺🇸
Oregon Health & Science Univerity, Portland, Oregon, United States
The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery
- Conditions
- Interventions
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2023-10-02
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT05714007
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
- Conditions
- Interventions
- First Posted Date
- 2022-07-18
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Women and Infants Hospital of Rhode Island
- Target Recruit Count
- 746
- Registration Number
- NCT05462704
- Locations
- 🇺🇸
Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States
🇺🇸Oregon Health and Sciences Uiversity Medical Center, Portland, Oregon, United States
🇺🇸Heme-on-Call, Miami, Florida, United States
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
- Conditions
- Interventions
- First Posted Date
- 2022-06-07
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 82
- Registration Number
- NCT05407987
- Locations
- 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age with Iron Deficiency Anemia
- Conditions
- Interventions
- First Posted Date
- 2022-01-05
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Pharmacosmos A/S
- Target Recruit Count
- 200
- Registration Number
- NCT05179226
- Locations
- 🇺🇸
Pharmacosmos Investigational Site, Miami, Florida, United States
A Clinical Trial Assessing the Efficacy of Intravenous Iron for the Treatment of Anemia Following Cardiac Surgery
- Conditions
- Interventions
- First Posted Date
- 2020-10-29
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Michael Kremke
- Target Recruit Count
- 110
- Registration Number
- NCT04608539
- Locations
- 🇩🇰
Aarhus University Hospital, Aarhus, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.